Virtual Education Program for Congenital Adrenal Hyperplasia
Trial Summary
The trial protocol does not specify whether you need to stop taking your current medications, so it's best to discuss this with the study team or your doctor.
Research on transition programs for chronic illnesses shows that having structured education and support during the transition to adult care can improve patients' ability to manage their health and increase satisfaction with care. Similar programs for conditions like ADHD have shown improved transition competence, suggesting that virtual education could be beneficial for patients with Congenital Adrenal Hyperplasia as well.
12345The research articles provided do not contain specific safety data for the Virtual Education Program for Congenital Adrenal Hyperplasia or similar virtual education programs. They focus on the transition to virtual formats in various medical education contexts during the COVID-19 pandemic, but do not address safety concerns related to these programs.
678910The Virtual Education Program for Congenital Adrenal Hyperplasia is unique because it focuses on educating adolescents to manage their own health as they transition from pediatric to adult care, rather than directly treating the condition itself. This approach is designed to empower patients with knowledge and skills for self-management, which is different from traditional medical treatments that focus on medication or direct medical intervention.
2451112Eligibility Criteria
This trial is for adolescents and young adults aged 16 to 22 with Congenital Adrenal Hyperplasia (CAH), who are already part of the Natural History Study Protocol 06-CH-0011. They must be able to understand English, have internet access, and commit to all study procedures for a year.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Education
Participants receive an 11-minute educational video on CAH focusing on transitional goals
Follow-up Education
Participants receive CAH education again at 6 months
Final Assessment
Participants repeat the questionnaires from their first visit to assess transition readiness and other outcomes
Follow-up
Participants are monitored for safety and effectiveness after the intervention